Dietary Supplementation With Non-Digestible Oligosaccharides Reduces Allergic Symptoms and Supports Low Dose Oral Immunotherapy in a Peanut Allergy Mouse Model

Molecular Nutrition and Food Research - United Kingdom
doi 10.1002/mnfr.201800369
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Wiley

Related search

Non-Digestible Oligosaccharides scFOS/lcFOS Facilitate Safe Subcutaneous Immunotherapy for Peanut Allergy

Clinical and Molecular Allergy
AllergyImmunologyMolecular Biology
2019English

Peanut Allergy and Oral Immunotherapy

Hong Kong Medical Journal
Medicine
2019English

Predictors of Allergic Symptoms and Anaphylaxis During Peanut Oral Immunotherapy

Journal of Allergy and Clinical Immunology
AllergyImmunology
2019English

AR101 Oral Immunotherapy for Peanut Allergy

Pediatrics
Child HealthPediatricsPerinatology
2019English

Mannosylated Nanoparticles for Oral Immunotherapy in a Murine Model of Peanut Allergy

Journal of Pharmaceutical Sciences
Pharmaceutical Science
2019English

Oral Allergy Symptoms and Pollen Sensitization in Tree Nut Allergic Subjects Receiving Walnut Oral Immunotherapy (WOIT)

Journal of Allergy and Clinical Immunology
AllergyImmunology
2016English

Frequency of Allergic Symptoms During Build-Up and Maintenance Phases of Peanut Oral Immunotherapy

Journal of Allergy and Clinical Immunology
AllergyImmunology
2019English

Oral Immunotherapy to Peanut in Children With Mild and Moderate Peanut Allergy Results in Long Term Tolerance

Journal of Allergy and Clinical Immunology
AllergyImmunology
2019English

The Safety of Peanut Oral Immunotherapy in Peanut-Allergic Subjects in a Single-Center Trial

International Archives of Allergy and Immunology
MedicineAllergyImmunology
2012English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy